Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I love that video. Happy you posted it. Looking forward to next week. Have a great day!
Future Farm Expands Management Team and Provides Information on Voluntary Shareholder Warrant Conversion
PR Newswire
VANCOUVER, British Columbia , December 14, 2017
VANCOUVER, British Columbia , December 14, 2017 /PRNewswire/ --
Future Farm Technologies Inc. (the "Company" or "Future Farm") (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that it has hired George Groccia as a Project Manager consultant to oversee the Company's many projects in different stages of development.
Mr. Groccia is an Industrial/Organizational Psychologist with a track record of helping businesses grow to their fullest potential. Having earned his MA at Golden Gate University , Mr. Groccia applied his craft as a consultant with Bearing Point , liaising with top executives within Phillips Life Sciences division. A career entrepreneur, Mr. Groccia grew a local business to gain national relevance in the hospitality sector guiding the profitable sale of his company. Passionate about the social and political climate in Boston , Mr. Groccia helped lay the foundation for Boston's first all women ride-share company called Chariot For Women, where it finally came to be known as Safr.
In addition to project management services, Mr. Groccia will also provide Future Farm with organizational and structural support and make recommendations for culture identification and growth.
"We are very pleased to have Mr. Groccia on board," says William Gildea , Future Farm's CEO and Chairman. " Future Farm has many projects in different stages of development and George's skill set is neatly aligned with our needs for maintaining project oversight and accountability."
"I am excited about the opportunity to work with Future Farm ," says Mr. Groccia. "I look forward to helping the Company establish best practices and organizational structure for each of its projects."
As previously announced, the Company has raised $1.4 Million through the voluntary conversion of both its $0.35 and $ 0.37 warrants. Shareholders who have participated in the Company's two offerings in 2017 and have not yet exercised their right to convert the warrants into FFT common stock may still purchase shares at the exercise price of $0.35 or $ 0.37 per share. The $0.35 per share warrants will expire and be worthless after January 11, 2018 . The $0.37 per share warrants will expire and be worthless after March 7, 2018 .
Shareholders wishing to exercise their warrants are asked to contact the Company prior to December 20, 2017 by following the instructions below:
Enquiries by email:
Belinda Tyldesley at closingbellservices@gmail.com
Original Warrant Exercise Forms and payment by way of certified cheque or bank draft payable to "Future Farm Technologies Inc." should be delivered to #510-580 Hornby Street, Vancouver, BC V63 3B6 or by wire transfer in Canadian funds to Future Farm Technologies Inc. Wire instructions will be provided upon request.
On behalf of the Board,
Future Farm Technologies Inc.
William Gildea , CEO & Chairman
About Future Farm
Future Farm Technologies Inc. is a Canadian company with projects throughout North America including California , Florida and Maryland . The Company's business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants, with a focus on cannabis. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generates yields up to 10 times greater per square foot of land. The contained system provides many other benefits including 90% less water, fertilizer and land used, less travel costs, seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability. The Company also utilizes a leading cannabis oil extraction technology, which enables the Company to process 20lbs/hour of cannabis plant to yield approximately 908 grams/hour of oil.
The Company is also in the business of designing and distributing LED lighting solutions utilizing the COB and MCOB technology. The Company is focused on delivering cost efficient lighting to North America via advanced e-commerce sites the Company owns and operates. LEDCanada.com, which caters to B2B customers, is a supplier of the newest and highest demand LED solutions. The Company also owns and operates COBGrowlights.com, which caters to both large and small agriculture green houses and controlled cultivation centers.
The Company recently acquired the exclusive right to use a patented, augmented reality (AR) technology in the cannabis industry. As described in more detail above, the Company has decided to spin this asset off to its shareholders.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward- looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
For further information, contact:
William Gildea ,
Director,
+1-617-834-9467
SOURCE Future Farm Technologies Inc.
(END) Dow Jones Newswires
12-14-17 0800ET
NEW YORK , Dec. 14, 2017 (GLOBE NEWSWIRE) -- HempAmericana, Inc. (OTC:HMPQ) (the “Company”) is excited to confirm that it has secured sufficient necessary raw hemp material for initial production activities to be processed upon delivery of the Company’s new 200-liter Supercritical C02 Extractor machine in January, 2018. Given strong demand estimates (the CBD market is anticipated to grow to $2.1 billion by 2020), additional supplier agreements are being pursued.
Management is excited about its progress in coordinating supplier agreements at this stage given the developing status of the hemp market. Supply chain logistics in the hemp space are still a work in progress for those involved in high-capacity production activities, which presents unconventional challenges for companies like HempAmericana .
Company CEO, Salvadore Rosillo stated, “Given the scope of our ambitions, attaining adequate raw inputs was identified early on as a key challenge. The fact that we are now ahead of the game with this facet of the process is extremely important. We have secured a 17k square foot facility and machinery capable of unmatched productive output at this point, and we have begun to coordinate our distribution network. Access to raw material inputs was really the only remaining obstacle to reaching our primary objective: firing up a world class CBD Oil production operation over coming months!”
The Company has been gearing up for a high-capacity producer role in the CBD Oil marketplace for the better part of the past year given consistent projections of high demand growth over the next 3-5 years. Analyst projections have consistently demonstrated a high-conviction bias toward powerful growth over that period, with estimates ranging from 650-700% market growth, according to industry research as reported by the Hemp Business Journal .
About HempAmericana, Inc. HempAmericana is currently in the rolling paper and CBD oil business using the brand name Weed Got Oil. Search Rolling Thunders hemp papers on YouTube for a product demonstration of the Company's papers. The company owns an extraction machine and now plans to become a leader in the CBD oil market by establishing three laboratories for the extraction and research of the oils contained in the hemp plant. HempAmericana also researches, develops and sells products made of industrial hemp. See more at http://www.HempAmericana.net.
Safe Harbor:
Safe Harbor Provision Cautionary statement for purposes of the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995: Information in this news release contains forward-looking statements that involve risks, uncertainties and assumptions. If such risks or uncertainties materialize or such assumptions prove incorrect, the results of the Company and its consolidated subsidiaries could differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks, uncertainties and assumptions include the execution and performance of contracts by the Company and its customers, suppliers and partners. Please also review Hemp Americana annual and quarterly financials for a more complete discussion of risk factors. The Company disclaims any obligation to update or revise statements contained in this news release based on new information or otherwise. This communication shall not constitute an offer to sell or the solicitation of an offer to buy securities nor shall there be any sale of these securities in any state in which such solicitation or sale would be unlawful prior to registration or qualification of these securities under the laws of any such state.
Contact: HempAmericana.net Salvador Rosillo
HempAmericana, Inc. Phone: (888) 977-7985
Image: Primary Logo
Source: HempAmericana, Inc.
This is great news! $SRUPD
If this company does half what it is capable of it will still rock.
Yes, I believe so. IMLFF is one of my favorites. It may take a while but they will light it up.
Yep, being patient. This is actually better than expected since the CE was listed.
Just got back, last check was 0.014. This is depressing. Was hoping for a a better day.
I saw the article on gun restrictions in Hawaii and in my opinion thought it was sort of silly. I do not think people who use marijuana, smoke up and want to go shoot people. Back in the day I did not want to tie my shoes, much less cause trouble. How come people who drink whiskey can own guns, they are much more likely to be violent, or is this where the law is going. Crazy times we are a livin' in. Just thinking about CBD being a schedule 1 drug aggravates me as it has medicinal value and no THC. Something tells me that the end game for the laws are not what I may think they are.
Wow, was not expecting to get home and see that. Maybe it will take a day or two for people to find and figure out that XXII is the top of the heap for VLN tobacco.
I hope so. I am not a technical trader (yet). But I always appreciate the ones who are to reinforce my opinion on a company or technology I am invested in. These guys at IMLFF have lightning in their pocket with the biosynthesis technology and not just huge potential for the specific pharmaceutical CDB but the great unknown amounts of other compounds that may be able to manufacture cleanly. I am a big fan $IMLFF
NEW YORK , Dec. 08, 2017 (GLOBE NEWSWIRE) -- NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF), a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems.
The publication, titled, “Purified Cannabinoids Open New Opportunities in Pain Management,” reviews innovative methods cannabis companies are using to produce cannabinoid products and therapies for the lucrative pain management market.
To view the full publication, visit: https://www.networknewswire.com/purified-cannabinoids-open-new-opportunities-pain -management/
“As consumer acceptance continues to propel demand to unprecedented levels, companies such as InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) are making waves in the advancement of cannabinoid compounds as a medical solution in pain management and other indications. The biopharmaceutical company focuses its efforts in the development of novel therapies surrounding the extensive pharmacology of cannabinoids (cannabis’ bioactive compounds) and innovative drug delivery systems.
“The company’s proprietary biosynthesis process has the ability to combine the intrinsic safety and efficacy of natural drug structures with the convenience, control and quality of a laboratory-based manufacturing process. Aside from significant cost savings, this process enables enhanced production, purification, and quality control compared to the typical grow-harvest-extract-purify methods employed by other companies. Notably, InMed’s biosynthesis system allows the manufacturing of all of the 90+ naturally occurring cannabinoids at a relatively low cost, regardless of how rare each compound may be in nature.”
About InMed
InMed is a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. InMed conducts research, discovery, preclinical, clinical, regulatory, manufacturing and commercial development activities for its product candidates. InMed’s proprietary bioinformatics database assessment tool, the biosynthesis manufacturing process and its drug development programs are the fundamental value drivers of the company. For more information, visit www.InMedPharma.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today's market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
NNW Contact:
NetworkNewsWire (NNW) New York, New York www.NetworkNewsWire.com 212.418.1217 Office Editor@NetworkNewsWire.com
Source: NetworkNe
So on Sunday the 10th of December the crypto market will crash just so the stock can be shorted. Why not Monday the 11th?
Why the 10th?
Awesome technology. Very exciting. Thank for the link.
I think so too. I wish I had a crap load more of it.
No doubt. This is one I will be accumulating as I think it has huge potential, but ALRT will take time to develop.
911
NEW YORK , Dec. 07, 2017 (GLOBE NEWSWIRE) -- via NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE:IN) (OTCQB:IMLFF), a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems.
The publication, titled, “Advanced Biosynthesis Setting New Standards for Cannabinoid-based Pain Management,” reviews InMed’s cannabinoid manufacturing process and its potential in pain management.
To view the full publication, visit: https://www.networknewswire.com/advanced-biosynthesis-setting-new-standards-canna binoid-based-pain-management
“Other biopharmaceutical companies may produce cannabinoids in the laboratory using chemical synthesis, but there’s a litany of drug development efforts with synthetic molecules that have failed. The proprietary biosynthesis process used by InMed Pharmaceuticals , Inc.’s (CSE:IN) (OTCQB:IMLFF) is unique. Producing cannabinoids that are identical to naturally occurring compounds is transformative for drug development. By using its proprietary process, InMed is able to manufacture exact cannabinoid replicas for use in research. This novel breakthrough gives InMed scientists the ability to manufacture all 90+ cannabinoid compounds identical to those found in nature and the ability to consistently, reliably and accurately test efficacy and safety. In addition, InMed’s cost-effective biosynthesis process enhances production, purification, and quality control as opposed to other chemical manufacturing methods. InMed’s biopharmaceutical approach to the production of pharmaceutical grade, bio-identical cannabinoids is disruptive in the development of pharmaceutical cannabinoids for research and drug creation. The company’s high-yield manufacturing process also provides simpler scale-up and systems optimization, as well as the production of minor cannabinoids that are economically impractical to extract from plant sources.
“To protect this invaluable asset, InMed has filed a provisional patent for the biosynthesis of cannabinoids (http://nnw.fm/RPTj0), and the company continues to use the technology to expand its pipeline for treating a variety of medical conditions.
“InMed’s cannabinoid biosynthesis process is complemented by its bioinformatics drug and disease targeting tool. Bioinformatics is a high-efficiency, computer-assisted approach to predicting the therapeutic potential and medicinal properties of individual cannabinoids against particular medical conditions. InMed’s proprietary approach applies comprehensive algorithms to integrate the data from various bioinformatics databases, including a vast database of the chemical structures of approved pharmaceuticals, with InMed’s proprietary cannabinoid database and know-how.”
About InMed
InMed is a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. InMed conducts research, discovery, preclinical, clinical, regulatory, manufacturing and commercial development activities for its product candidates. InMed’s proprietary bioinformatics database assessment tool, the biosynthesis manufacturing process and its drug development programs are the fundamental value drivers of the company. For more information, visit www.InMedPharma.com.
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today's market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.
Corporate Communications Contact:
Michael McCarthy Managing Director NetworkNewsWire (NNW) New York, New York www.NetworkNewsWire.com 212.418.1217 Office Michael@NetworkNewsWire.com
Sou
I guess the pepto and whiskey will be unnecessary today. Fingers crossed, candles lit and chicken bones at the ready
I am here and excited. Bought snacks and took the morning off to see what happens I think today will be a good day.
I was thinking earlier what will happen when official news comes out. Holy Cow.
That is more like it. The last couple days have been like watching paint dry.
Just checked in for today and looks like IMLFF had a good one. WOOT!
That is awesome!
VANCOUVER, British Columbia , December 5, 2017 /PRNewswire/ --
Future Farm Technologies Inc. (the "Company" or " Future Farm ") (CSE: FFT) (OTCQB: FFRMF) is pleased to announce it has entered into an offer to Purchase Real Estate for the acquisition of a 15,000-sq ft building in Providence, Rhode Island . The building is located in a M-1 zone, which legally permits the cultivation of cannabis by right. Once licensed, the Company expects that this property will be used as a licensed medical marijuana cultivation space, providing wholesale cannabis to Rhode Island's state-sanctioned dispensaries.
"With this asset purchase, Future Farm is building a solid foundation in the Northeastern part of the United States ," says Bill Gildea , CEO of Future Farm . "The Northeast has a large population but has lagged behind the Southwest in the permitting of cannabis cultivation and dispensaries, which creates opportunity." Rhode Island is in the New England region of the Northeastern United States and is the second most densely populated of the 50 United States.
The definitive terms of this transaction shall be disclosed in the closing press release.
On behalf of the Board,
Future Farm Technologies Inc.
William Gildea , CEO & Chairman
About Future Farm
Future Farm Technologies Inc. is a Canadian company with projects throughout North America including California , Florida and Maryland . The Company's business model includes developing and acquiring technologies that will position it as a leader in the evolution of Controlled Environment Agriculture (CEA) for the global production of various types of plants, with a focus on cannabis. Future Farm provides scalable, indoor CEA systems that utilize minimal land, water and energy regardless of climate, location or time of year and are customized to grow an abundance of crops close to consumers, therefore minimizing food miles and its impact to the environment. The Company holds an exclusive, worldwide license to use a patented vertical farming technology that, when compared to traditional plant production methods, generate yields up to 10 times greater per square foot of land. The contained system provides many other benefits including 90% less water, fertilizer and land used, less travel costs, seed to sale security, scalability, consistency due to year-round production, cost control, product safety and purity by eliminating environmental variability. The Company also utilizes a leading cannabis oil extraction technology, which enables the Company to process 20lbs/hour of cannabis plant to yield approximately 908 grams/hour of oil.
The Company is also in the business of designing and distributing LED lighting solutions utilizing the COB and MCOB technology. The Company is focused on delivering cost efficient lighting to North America via advanced e-commerce sites the Company owns and operates. LEDCanada.com, which caters to B2B customers, is a supplier of the newest and highest demand LED solutions. The Company also owns and operates COBGrowlights.com, which caters to both large and small agriculture green houses and controlled cultivation centers.
The Company recently acquired the exclusive right to use a patented, augmented reality (AR) technology in the cannabis industry. The Company will work with its partner to merge AR and ad-tech with the cannabis industry through the CannaCube LiveTM platform.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this press release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
For further information: William Gildea Director +1-617-834-9467
SOURCE Future Farm Technologies Inc.
You would think this would be more important than "the next couple months". Hopefully sooner than later.
Phoenix, AZ , Dec. 05, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire is the sole producer of the Uptick Network “Stock Day” Podcast keeping investors and shareholders up-to-date on company news and bringing transparency to the micro-cap sector of the market. The host of Stock Day, CEO and founder Everett Jolly , recently interviewed a new CEO and a brand new company on the podcast to shed light on the computer technology industry.
Everett Jolly had welcomed on Kevin Cornell , the CEO of AmbiCom Holdings, Inc. (OTCPink:ABHI, the “Company”), who had discussed the background of the company and elaborated on how AmbiCom’s product can make a difference on any PC or server. Mr. Cornell discussed AmbiCom’s patented product Veloxum™, which optimizes physical and virtual operating system achieving greater performance and capacity with Active Continuous Optimization (ACO). Continuing the interview, Mr. Jolly brought up the matter of how big this market is and Mr. Cornell answered on the world-wide need for computer technology and the revenue within that market. Furthermore, Mr. Jolly had received a few emails regarding AmbiCom and asked Mr. Cornell when he will be bringing his fillings current with the new auditor and when the stop sign will be taken off of the ticker symbol.
CEO Kevin Cornell replies to the question with, “We’re working on it right now. The goal is to get it done in the next couple of months. We’ve got the auditor engaged and we’ve brought in an outside company who specializes in that as well. We’re working as hard and as fast as we can to get current with all of our fillings. In the next month or two you should see that stop sign come down.”
To listen to the full interview please click here or the following link: https://upticknewswire.com/featured-interview-ceo-kevin-cornell-of-ambicom-holdin gs-inc-otcpink-abhi
About AmbiCom Holdings , Inc. AmbiCom Holdings Inc. , headquarters in Santa Cruz, California , searches out, acquires and/or invests in unique technologies that have the potential for wide adoption in large markets. AmbiCom looks for mature management teams that have a history of successfully converting new concepts in to products.Of interest are high margin products that have the ability to enhance user’s experience while generating positive return on investment. We are acutely aware of our responsibility to the investors that have placed their trust in our abilities to effectively manage the assets of AmbiCom on their behalf.
For further information, visit www.ambicom.com.
About Uptick Newswire and the “Stock Day Podcast”Uptick Newswire is a private company reaching out to the masses keeping investors and shareholders up to date on company news and bringing transparency to the undervalued, undersold, micro-cap stocks of the market and is the sole producer of the Uptick Network “Stock Day” Podcast. The Uptick Network “Stock Day” Podcast is an extension of Uptick Newswire and has recently launched the Video Interview Studio located in Phoenix Arizona with its new host Kathryn Donnelly .
At the very least Sessions needs to go. Trump has bigger fish to fry and I think the dollars will talk in the coming months/years.
On the federal level. States for the most part are ready or will be as things progress. It is maddening all the ass dragging that goes on. I thought we would be where we are right now in the ‘80’s. Seems funny to me that D.C. has MJ yet the Shenandoah Valley, right down the road, does not. I am still hearing “gateway drug” used in a sentence.
Sessions has said before that he only enforces the law, he does not make the law. He also has an archaic view of marijuana. Somehow “it has no recognized medical benefits” needs to change and it needs to be unscheduled. It should be treated like alcohol but with health benefits. WTF, is alcohol recognized as having medical benefits?
This great news, Right? I am fairly new to ACBFF and do not have much skin in it, but I would think this is great news.
No doubt about that.I watched the x ray industry go from film to wireless digital imaging (DR) in the last 9 or 10 years and nobody is looking back. Great stuff.
Where are you viewing the share structure?
Shooting up. Like this one!
Just a thought, and now I know. Thanks.
Good morning. I am up, properly caffeinated, and have until noon to watch FVRD recover.
I had a thought last night. I noticed that individuals use a dollar sigh in front of ticker symbols ie; $FVRD. In order to better allow individual "tune in" to or search out information would it not be better to use a hash tag ei; #FVRD. This way it shows up in searches better. Just a thought.
Just when I was starting to think it could not get better.
Chicago Paul, Thanks. I was out all day and saw the chart and thought something happened. This company is strong and smart and I have high hopes for them.
I lived in Rogers Park, Edgewater and eventually Cicero over a 20 year period before leaving Illinois. You still in the windy city? If so send me a double char chili dog with cheese